![European Society of Cardiology on Twitter: "#BRACE CORONA trial: results indicate no clinical benefit from routinely suspending #ACEinhibitor or #ARB therapy in hospitalised patients with mild to moderate #COVID-19 https://t.co/VkQRBGUwXZ #ESCCongress ... European Society of Cardiology on Twitter: "#BRACE CORONA trial: results indicate no clinical benefit from routinely suspending #ACEinhibitor or #ARB therapy in hospitalised patients with mild to moderate #COVID-19 https://t.co/VkQRBGUwXZ #ESCCongress ...](https://pbs.twimg.com/media/Eg1F1tKWoAEc4sP.jpg)
European Society of Cardiology on Twitter: "#BRACE CORONA trial: results indicate no clinical benefit from routinely suspending #ACEinhibitor or #ARB therapy in hospitalised patients with mild to moderate #COVID-19 https://t.co/VkQRBGUwXZ #ESCCongress ...
![Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial ... Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial ...](https://ars.els-cdn.com/content/image/1-s2.0-S0002870320301381-ga1.jpg)
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial ...
![Register Now To Our Webinar On Clinical Trials During The Corona Virus Pandemic: Pragmatic Approach To The Risks! - EORTC Register Now To Our Webinar On Clinical Trials During The Corona Virus Pandemic: Pragmatic Approach To The Risks! - EORTC](https://www.eortc.org/app/uploads/2020/03/efgcp-webinar_900x400_2020.jpg)
Register Now To Our Webinar On Clinical Trials During The Corona Virus Pandemic: Pragmatic Approach To The Risks! - EORTC
![European Society of Cardiology on Twitter: "#BRACE CORONA trial: results indicate no clinical benefit from routinely suspending #ACEinhibitor or #ARB therapy in hospitalised patients with mild to moderate #COVID-19 https://t.co/VkQRBGUwXZ #ESCCongress ... European Society of Cardiology on Twitter: "#BRACE CORONA trial: results indicate no clinical benefit from routinely suspending #ACEinhibitor or #ARB therapy in hospitalised patients with mild to moderate #COVID-19 https://t.co/VkQRBGUwXZ #ESCCongress ...](https://pbs.twimg.com/media/Eg1F2-YXsAAuZp5.jpg)
European Society of Cardiology on Twitter: "#BRACE CORONA trial: results indicate no clinical benefit from routinely suspending #ACEinhibitor or #ARB therapy in hospitalised patients with mild to moderate #COVID-19 https://t.co/VkQRBGUwXZ #ESCCongress ...
![Amazon | Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic | Schueler, Peter | Biological Sciences Amazon | Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic | Schueler, Peter | Biological Sciences](https://m.media-amazon.com/images/I/61FeQxapZZL._AC_UF1000,1000_QL80_.jpg)